Skip to search boxSkip to navigationSkip to main content

Differential activation of the ER stress factor XBP1 by oligomeric assemblies

  • ,
  • Y. Zhanga(Author)
    ,
  • M.J. Guerrero-Muñozb(Author)
    ,
  • R. Kayedb(Author)
    ,
  • D.E. Rincon-Limasa(Author)
    ,
  • P. Fernandez-Funeza(Author)
  • aUniversity of Florida
    ,
  • bUniversity of Texas Medical Branch at Galveston
Research Output: Contribution to journal Article Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Metrics

SciVal
Citations
45
Scopus
Citations
SciVal
FWCI
0.74
SciVal
Author count
6
SciVal
Paper percentile
64

PlumX, opens in new tab

Citations
45
Captures
80

Abstract

Several neurodegenerative disorders are characterized by protein misfolding, a phenomenon that results in perturbation of cellular homeostasis. We recently identified the protective activity of the ER stress response factor XBP1 (X-box binding protein 1) against Amyloid-ß1-42 (Aß42) neurotoxicity in cellular and Drosophila models of Alzheimer's disease. Additionally, subtoxic concentrations of Aß42 soluble aggregates (oligomers) induced accumulation of spliced (active) XBP1 transcripts, supporting the involvement of the ER stress response in Aß42 neurotoxicity. Here, we tested the ability of three additional diseaserelated amyloidogenic proteins to induce ER stress by analyzing XBP1 activation at the RNA level. Treatment of human SY5Y neuroblastoma cells with homogeneous preparations of α-Synuclein (α-Syn), Prion protein (PrP106-126), and British dementia amyloid peptide (ABri1-34) confirmed the high toxicity of oligomers compared to monomers and fibers. Additionally, α-Syn oligomers, but not monomers or fibers, demonstrated potent induction of XBP1 splicing. On the other hand, PrP106-126 and ABri1-34 did not activate XBP1. These results illustrate the biological complexity of these structurally related assemblies and argue that oligomer toxicity depends on the activation of amyloid-specific cellular responses.

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1707-1717 (11 pages)

Journal (Volume, Issue Number)

Neurochemical Research (Volume 37, Issue 8)

Publication milestones

  • Published - 08/2012

Publication status

Published - 08/2012

ISSN

0364-3190

External Publication IDs

  • ORCID: /0000-0003-2511-949X/work/43281178
  • Scopus: 84864347798
  • PubMed: 22528838
  • WOS: 000305949100012

Funding Details

FundersFunding numbers
Mitchell Center for Neurodegenerative Diseases
-
UF Department of Neurology
-
National Institutes of Health
-
OD
DP2OD002721
University of Texas Medical Branch at Galveston
-